HEADER ANTIBIOTIC 18-JUN-18 6GTH TITLE SERIAL FEMTOSECOND CRYSTALLOGRAPHY AT MEGAHERTZ PULSE RATES COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-LACTAMASE; COMPND 3 CHAIN: A; COMPND 4 EC: 3.5.2.6; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: KLEBSIELLA PNEUMONIAE; SOURCE 3 ORGANISM_TAXID: 573; SOURCE 4 GENE: CTX-M-14; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SER-BETA-LACTAMASE, INHIBITOR, COMPLEX, AVIBACTAM, ANTIBIOTIC EXPDTA X-RAY DIFFRACTION AUTHOR M.WIEDORN,D.OBERTHUER,N.WERNER,R.SCHUBERT,T.A.WHITE,A.MANCUSO, AUTHOR 2 M.PERBANDT,C.BETZEL,A.BARTY,H.CHAPMAN REVDAT 5 17-JAN-24 6GTH 1 REMARK REVDAT 4 13-DEC-23 6GTH 1 REMARK HETSYN REVDAT 3 14-NOV-18 6GTH 1 COMPND REMARK REVDAT 2 17-OCT-18 6GTH 1 JRNL REVDAT 1 10-OCT-18 6GTH 0 JRNL AUTH M.O.WIEDORN,D.OBERTHUR,R.BEAN,R.SCHUBERT,N.WERNER,B.ABBEY, JRNL AUTH 2 M.AEPFELBACHER,L.ADRIANO,A.ALLAHGHOLI,N.AL-QUDAMI, JRNL AUTH 3 J.ANDREASSON,S.APLIN,S.AWEL,K.AYYER,S.BAJT,I.BARAK,S.BARI, JRNL AUTH 4 J.BIELECKI,S.BOTHA,D.BOUKHELEF,W.BREHM,S.BROCKHAUSER, JRNL AUTH 5 I.CHEVIAKOV,M.A.COLEMAN,F.CRUZ-MAZO,C.DANILEVSKI,C.DARMANIN, JRNL AUTH 6 R.B.DOAK,M.DOMARACKY,K.DORNER,Y.DU,H.FANGOHR,H.FLECKENSTEIN, JRNL AUTH 7 M.FRANK,P.FROMME,A.M.GANAN-CALVO,Y.GEVORKOV,K.GIEWEKEMEYER, JRNL AUTH 8 H.M.GINN,H.GRAAFSMA,R.GRACEFFA,D.GREIFFENBERG,L.GUMPRECHT, JRNL AUTH 9 P.GOTTLICHER,J.HAJDU,S.HAUF,M.HEYMANN,S.HOLMES,D.A.HORKE, JRNL AUTH10 M.S.HUNTER,S.IMLAU,A.KAUKHER,Y.KIM,A.KLYUEV,J.KNOSKA,B.KOBE, JRNL AUTH11 M.KUHN,C.KUPITZ,J.KUPPER,J.M.LAHEY-RUDOLPH,T.LAURUS, JRNL AUTH12 K.LE CONG,R.LETRUN,P.L.XAVIER,L.MAIA,F.R.N.C.MAIA,V.MARIANI, JRNL AUTH13 M.MESSERSCHMIDT,M.METZ,D.MEZZA,T.MICHELAT,G.MILLS, JRNL AUTH14 D.C.F.MONTEIRO,A.MORGAN,K.MUHLIG,A.MUNKE,A.MUNNICH,J.NETTE, JRNL AUTH15 K.A.NUGENT,T.NUGUID,A.M.ORVILLE,S.PANDEY,G.PENA, JRNL AUTH16 P.VILLANUEVA-PEREZ,J.POEHLSEN,G.PREVITALI,L.REDECKE, JRNL AUTH17 W.M.RIEKEHR,H.ROHDE,A.ROUND,T.SAFENREITER,I.SARROU,T.SATO, JRNL AUTH18 M.SCHMIDT,B.SCHMITT,R.SCHONHERR,J.SCHULZ,J.A.SELLBERG, JRNL AUTH19 M.M.SEIBERT,C.SEURING,M.L.SHELBY,R.L.SHOEMAN,M.SIKORSKI, JRNL AUTH20 A.SILENZI,C.A.STAN,X.SHI,S.STERN,J.SZTUK-DAMBIETZ,J.SZUBA, JRNL AUTH21 A.TOLSTIKOVA,M.TREBBIN,U.TRUNK,P.VAGOVIC,T.VE,B.WEINHAUSEN, JRNL AUTH22 T.A.WHITE,K.WRONA,C.XU,O.YEFANOV,N.ZATSEPIN,J.ZHANG, JRNL AUTH23 M.PERBANDT,A.P.MANCUSO,C.BETZEL,H.CHAPMAN,A.BARTY JRNL TITL MEGAHERTZ SERIAL CRYSTALLOGRAPHY. JRNL REF NAT COMMUN V. 9 4025 2018 JRNL REFN ESSN 2041-1723 JRNL PMID 30279492 JRNL DOI 10.1038/S41467-018-06156-7 REMARK 2 REMARK 2 RESOLUTION. 1.69 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.4_1496 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.69 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.60 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 27838 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.179 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.210 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.320 REMARK 3 FREE R VALUE TEST SET COUNT : 2037 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 34.6105 - 4.1657 1.00 1904 149 0.1817 0.1725 REMARK 3 2 4.1657 - 3.3073 1.00 1798 141 0.1577 0.1826 REMARK 3 3 3.3073 - 2.8895 1.00 1761 141 0.1793 0.2134 REMARK 3 4 2.8895 - 2.6254 1.00 1707 139 0.1772 0.2180 REMARK 3 5 2.6254 - 2.4373 1.00 1727 138 0.1698 0.2450 REMARK 3 6 2.4373 - 2.2936 1.00 1719 137 0.1663 0.2395 REMARK 3 7 2.2936 - 2.1788 1.00 1702 130 0.1647 0.1954 REMARK 3 8 2.1788 - 2.0839 1.00 1689 134 0.1661 0.1924 REMARK 3 9 2.0839 - 2.0037 1.00 1698 132 0.1693 0.2130 REMARK 3 10 2.0037 - 1.9346 1.00 1703 134 0.1700 0.2460 REMARK 3 11 1.9346 - 1.8741 1.00 1703 133 0.1951 0.2482 REMARK 3 12 1.8741 - 1.8205 1.00 1640 130 0.2002 0.2764 REMARK 3 13 1.8205 - 1.7726 1.00 1720 136 0.2118 0.2557 REMARK 3 14 1.7726 - 1.7293 1.00 1642 132 0.2251 0.2777 REMARK 3 15 1.7293 - 1.6900 0.99 1688 131 0.2700 0.2960 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.170 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.480 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.55 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2020 REMARK 3 ANGLE : 1.223 2756 REMARK 3 CHIRALITY : 0.043 326 REMARK 3 PLANARITY : 0.006 362 REMARK 3 DIHEDRAL : 12.307 743 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6GTH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 18-JUN-18. REMARK 100 THE DEPOSITION ID IS D_1200010477. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-APR-18 REMARK 200 TEMPERATURE (KELVIN) : 290 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : FREE ELECTRON LASER REMARK 200 BEAMLINE : SPB/SFX REMARK 200 X-RAY GENERATOR MODEL : EUROPEAN XFEL BEAMLINE SPB/SFX REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.33 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : AGIPD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTFEL REMARK 200 DATA SCALING SOFTWARE : CRYSTFEL 0.6.3 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27838 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.690 REMARK 200 RESOLUTION RANGE LOW (A) : 34.603 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 65.99 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.3700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.69 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.75 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5TWD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CTX-M-14 MICROCRYSTALS FOR SFX WERE REMARK 280 PRODUCED USING A SEEDING APPROACH. CRYSTALS WERE GROWN BY REMARK 280 SITTING DROP VAPOR DIFFUSION AT 290 OVERNIGHT MIXING 1 REMARK 280 MICROLITER CTX-M-14 AT 20 MG ML-1 AND 1 MICROLITER PRECIPITANT REMARK 280 (40 % PEG8000, 200 MM LITHIUM SULFATE, 100 MM SODIUM ACETATE). REMARK 280 OBTAINED CRYSTALS (SPACE GROUP P212121) WERE CRUSHED AND A SEED REMARK 280 STOCK WAS PREPARED. TO OBTAIN MICROCRYSTALS THE UNDILUTED REMARK 280 SEEDSTOCK WAS USED FOR BATCH CRYSTALLIZATION SETUPS BY MIXING REMARK 280 VOLUMES OF 50 % CTX-M-14 WITH 10 % UNDILUTED SEED STOCK AND 40 % REMARK 280 PRECIPITANT SOLUTION., BATCH MODE, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 155.52000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 77.76000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 77.76000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 155.52000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10500 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLN A 31 CG CD OE1 NE2 REMARK 480 LYS A 38 CD CE NZ REMARK 480 GLN A 89 CG CD OE1 NE2 REMARK 480 LYS A 98 CD CE NZ REMARK 480 GLN A 253 NE2 REMARK 480 GLU A 272 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 69 -134.33 43.65 REMARK 500 VAL A 103 -135.17 -117.96 REMARK 500 SER A 220 -127.18 -101.82 REMARK 500 ARG A 255 143.27 -170.63 REMARK 500 GLU A 287 6.84 125.86 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NXL A 301 DBREF 6GTH A 27 288 UNP D2D9A0 D2D9A0_KLEPN 23 282 SEQRES 1 A 260 SER ALA VAL GLN GLN LYS LEU ALA ALA LEU GLU LYS SER SEQRES 2 A 260 SER GLY GLY ARG LEU GLY VAL ALA LEU ILE ASP THR ALA SEQRES 3 A 260 ASP ASN THR GLN VAL LEU TYR ARG GLY ASP GLU ARG PHE SEQRES 4 A 260 PRO MET CYS SER THR SER LYS VAL MET ALA ALA ALA ALA SEQRES 5 A 260 VAL LEU LYS GLN SER GLU THR GLN LYS GLN LEU LEU ASN SEQRES 6 A 260 GLN PRO VAL GLU ILE LYS PRO ALA ASP LEU VAL ASN TYR SEQRES 7 A 260 ASN PRO ILE ALA GLU LYS HIS VAL ASN GLY THR MET THR SEQRES 8 A 260 LEU ALA GLU LEU SER ALA ALA ALA LEU GLN TYR SER ASP SEQRES 9 A 260 ASN THR ALA MET ASN LYS LEU ILE ALA GLN LEU GLY GLY SEQRES 10 A 260 PRO GLY GLY VAL THR ALA PHE ALA ARG ALA ILE GLY ASP SEQRES 11 A 260 GLU THR PHE ARG LEU ASP ARG THR GLU PRO THR LEU ASN SEQRES 12 A 260 THR ALA ILE PRO GLY ASP PRO ARG ASP THR THR THR PRO SEQRES 13 A 260 ARG ALA MET ALA GLN THR LEU ARG GLN LEU THR LEU GLY SEQRES 14 A 260 HIS ALA LEU GLY GLU THR GLN ARG ALA GLN LEU VAL THR SEQRES 15 A 260 TRP LEU LYS GLY ASN THR THR GLY ALA ALA SER ILE ARG SEQRES 16 A 260 ALA GLY LEU PRO THR SER TRP THR VAL GLY ASP LYS THR SEQRES 17 A 260 GLY SER GLY ASP TYR GLY THR THR ASN ASP ILE ALA VAL SEQRES 18 A 260 ILE TRP PRO GLN GLY ARG ALA PRO LEU VAL LEU VAL THR SEQRES 19 A 260 TYR PHE THR GLN PRO GLN GLN ASN ALA GLU SER ARG ARG SEQRES 20 A 260 ASP VAL LEU ALA SER ALA ALA ARG ILE ILE ALA GLU GLY HET NXL A 301 28 HETNAM NXL (2S,5R)-1-FORMYL-5-[(SULFOOXY)AMINO]PIPERIDINE-2- HETNAM 2 NXL CARBOXAMIDE HETSYN NXL AVIBACTAM, BOUND FORM; NXL104, BOUND FORM FORMUL 2 NXL C7 H13 N3 O6 S FORMUL 3 HOH *200(H2 O) HELIX 1 AA1 SER A 27 GLY A 41 1 15 HELIX 2 AA2 CYS A 69 THR A 71 5 3 HELIX 3 AA3 SER A 72 GLU A 85 1 14 HELIX 4 AA4 GLN A 89 ASN A 92 5 4 HELIX 5 AA5 LYS A 98 LEU A 102 5 5 HELIX 6 AA6 ILE A 108 VAL A 113 5 6 HELIX 7 AA7 LEU A 119 TYR A 129 1 11 HELIX 8 AA8 ASP A 131 LEU A 142 1 12 HELIX 9 AA9 GLY A 144 ILE A 155 1 12 HELIX 10 AB1 PRO A 167 THR A 171 5 5 HELIX 11 AB2 THR A 182 LEU A 195 1 14 HELIX 12 AB3 GLY A 200 GLY A 213 1 14 HELIX 13 AB4 SER A 220 LEU A 225 5 6 HELIX 14 AB5 ARG A 274 GLU A 287 1 14 SHEET 1 AA1 5 THR A 55 TYR A 60 0 SHEET 2 AA1 5 ARG A 43 ASP A 50 -1 N LEU A 48 O VAL A 57 SHEET 3 AA1 5 LEU A 258 THR A 265 -1 O TYR A 263 N GLY A 45 SHEET 4 AA1 5 THR A 243 TRP A 251 -1 N ILE A 250 O LEU A 258 SHEET 5 AA1 5 THR A 230 GLY A 238 -1 N GLY A 236 O ASN A 245 SHEET 1 AA2 2 PHE A 66 PRO A 67 0 SHEET 2 AA2 2 THR A 180 THR A 181 -1 O THR A 181 N PHE A 66 SHEET 1 AA3 2 PRO A 94 ILE A 97 0 SHEET 2 AA3 2 GLY A 115 THR A 118 -1 O GLY A 115 N ILE A 97 LINK OG SER A 70 CAN NXL A 301 1555 1555 1.35 CISPEP 1 GLU A 166 PRO A 167 0 3.61 SITE 1 AC1 14 CYS A 69 SER A 70 ASN A 104 TYR A 105 SITE 2 AC1 14 SER A 130 ASN A 132 ASN A 170 THR A 216 SITE 3 AC1 14 LYS A 234 THR A 235 GLY A 236 SER A 237 SITE 4 AC1 14 HOH A 503 HOH A 518 CRYST1 41.840 41.840 233.280 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023901 0.013799 0.000000 0.00000 SCALE2 0.000000 0.027598 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004287 0.00000